The utilisation of continuous veno-venous haemofiltration for the removal of septic mediators in patients with systemic inflammatory response syndrome

Intensive and Critical Care Nursing

Volumn 19, Issue 4, 2003, Pages 207-214

  Ruffell, Alison J ^a  

^a O and G   (United Kingdom)

Author keywords

Haemofiltration; Septic shock; SIRS

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANAPHYLAXIS; ARTICLE; CLINICAL PRACTICE; CRITICAL ILLNESS; EVIDENCE BASED MEDICINE; HEMOFILTRATION; HUMAN; INTENSIVE CARE; MEDIATOR; MEDICAL ETHICS; MEDICAL RESEARCH; MORBIDITY; MORTALITY; NURSE; OUTCOMES RESEARCH; PATIENT CARE; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0042329916     PISSN: 09643397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0964-3397(03)00044-2     Document Type: Article

References (42)

1. American College of Chest Physicians/Society of Critical Care Medicine Conference 1992 Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 20:864-874
2. Bauer M, Redl H, Marzi I 2001 Prophylactic veno-venous haemofiltration and inflammatory response to multiple trauma. International Journal of Intensive Care Winter 8(4): 191-194
3. Beck C 1994 Achieving statistical power through research design sensitivity. Journal of Advanced Nursing 20(5): 912-916
4. Bellomo R 1995 Continuous haemofiltration as blood purification in sepsis. New Horizon 3(4): 732-737
5. Bellomo R, Tipping P, Boice N 1993 Continuous venovenous, haemofiltration with dialysis removes cytokines from the circulation of septic patients. Critical Care Medicine 21(4): 522-526
6. Bernard G 1999 Research in sepsis and acute respiratory distress syndrome: are we changing course? Critical Care Medicine 27(2): 434-436
7. Birdsall C 1991 Management Issues in Critical Care. Mosby, St. Louis
8. Block C, Manning H 2002 Prevention of acute renal failure in the critically ill. American Journal of Respiratory and Critical Care Medicine 165(3): 320-324
9. Bossink A, Groeneveld A, Hack C et al. 1998 Prediction and mortality in febrile medical patients. How useful are systemic inflammatory response syndrome and sepsis criteria? Chest 113: 1533-1541
10. Carroll D, Greenwood R, Lynch K et al. 1997 Barriers and facilitators to the utilization of nursing research. Clinical Nurse Specialist 11(5): 207-212
11. Christman J 1992 Potential treatment of sepsis syndrome with cytokine specific agents. Chest 102(2): 613-617
12. Cole L, Bellomo R, Journois D et al. 2001 High volume haemofiltration in human septic shock. Intensive Care Medicine 27(6): 778-786
13. Cole L, Bellomo R, Hart G et al. 2002 A phase II randomised, controlled trial of continuous haemofiltration in sepsis. Critical Care Medicine 30(1): 100-106
14. De Vriese A, Vanholder R, Pascual M et al. 1999 Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies? Intensive Care Medicine 25(9): 903-910
15. Ellis J 2000 Sharing the evidence: clinical practice benchmarking to improve continuously the quality of care. Journal of Advanced Nursing 32(1): 215-225
16. Fletcher N, Holt J, Brazier M, Harris J 1995 Ethics, Law and Nursing. Manchester University Press, Manchester
17. Fisher F 1993 Medical Ethics Today: Its Practice and Philosophy. BMJ, London
18. Fuhrman B, Abraham E, Dellinger R 1999 Futility of randomized, controlled ARDS trial: a new approach is needed. Critical Care Medicine 27(2): 431-433
19. Gennaro S, Hodnett E, Kearney M 2001 Making evidence-based practice a reality in your institution: evaluating the evidence and using the evidence to change clinical practice. American Journal of Maternal/Child 26(5): 236-244
20. Grootendorst A, van Bommell E, van der Hoven B et al. 1992 High volume haemofiltration improves right ventricular function of endotoxin-induced shock in the pig. Intensive Care Medicine 18(4): 235-240
21. Hoffman J, Hartl W, Deppisch R et al. 1996 Effects of haemofiltration on haemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Medicine 22(8): 1360-1367
22. Koperna T, Vogl S, Poschl G et al. 1998 Cytokine patterns in patients undergoing haemofiltration for treatment of multiple organ failure. World Journal of Surgery 22(5): 443-448
23. Levine M, Walters S, Lee H et al. 1994 User's guide to evidence-based medicine. The Journal of the American Medical Association 271(20): 1615-1619
24. Miller P 2001 Nurse-physician collaboration in an intensive care unit. American Journal of Critical Care 10(5): 341-350
25. Molnar Z, Euan S 1998 The role of elective haemofiltration in the management of sepsis and multiple organ failure. Orvasi Hetilap 139(20): 1229-1233
26. Molnar Z, Shearer E 1998 Veno-venous haemofiltration in the treatment of sepsis and the multiple organ dysfunction syndrome. British Journal of Intensive Care Jan/Feb: 12-20
27. Muckart D, Bhangwanjee S 1997 American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions of systemic inflammatory response syndrome. Critical Care Medicine 25(11): 1789-1795
28. Naswaray S 1999 Sepsis research: we must change course. Critical Care Medicine 27: 427-430
29. Opal S 1998 The uncertain value of the definition for SIRS. Chest 113: 1442-1443
30. Oudemanns van Straaten H, Bosman R, van der Spoel J et al. 1999 Outcome of critically ill patients treated with intermittent high volume haemofiltration: a prospective cohort analysis. Intensive Care Medicine 25(8): 814-821
31. Rogiers P, Zhang H, Smail N et al. 1999 CVVH improves cardiac performances by mechanisms other than TNF-α attenuation during septic shock. Critical Care Medicine 27(9): 1848-1855
32. Ronco C, Ricci Z, Bellomo R 2001 Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role of continuous veno-venous haemofiltration. Current Opinion in Nephrology and Hypertension 10(6): 755-761
33. Ryan D 1999 Septicaemic shock. Care of the Critically III 15(4): 112
34. Sander A, Armbruster W, Sander B et al. 1997 Haemofiltration increases IL,6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNFα plasma concentrations. Intensive Care Medicine 23(8): 878-884
35. Smith M 1998 Who should run intensive care units? Care of the Critically Ill 14(4): 113-115
36. Smith T 1999 Ethics in Medical Research: A Handbook of Good Practice. Cambridge University Press, Cambridge
37. Staubach K, Rau H, Kooistra. H et al. 1989 Can haemofiltration increase survival time in acute endotoxaemia? A porcine shock model. Progressive Clinical Biological Research 308: 821-826
38. Tetta C, Ronco C, Brendolan A 1999 Present and future options in continuous renal replacement therapies of sepsis and multi-organ failure. Minerva Anestesiologica 65(6): 419-426
39. Thijs L, Hack G 1995 Time course of cytokine levels in sepsis. Intensive Care Medicine 21(Suppl. 2): S258-S263
40. Thompson I, Melia K, Boyd K 2000 Nursing Ethics, 4th ed. Churchill Livingstone, Edinburgh
41. Tortora G, Grabowski S 2000 Principles of Anatomy and Physiology, 9th ed. Wiley, New York
42. Vincent J 1997 Dear SIRS, I'm sorry to say I don't like you. Critical Care Medicine 25(2): 372-374